Topics
July/August 2018 | Subfocus: Drug Delivery
Topical Drug Delivery for Retinal Disease Management
The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.
David S. Boyer, MD
October 21, 2026
Nanoscope Therapeutics Reports Sustained Visual Responses with OCT-Guided Nonviral Gene Delivery in Preclinical Study
Alcon Acquires Neurotech Pharmaceuticals for $550 Million, Adding Encelto to Retina Portfolio
October 20, 2026
EyePoint to Shift Focus, Cut Workforce Following Phase 3 Duravyu Results
October 19, 2026
Second Phase 3 Trial of Duravyu in Wet AMD Misses Primary Endpoint
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
